Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries

Although health technology assessment (HTA) systems base their decision making process either on economic evaluations or comparative clinical benefit assessment, a central aim of recent approaches to value measurement, including value based assessment and pricing, points towards the incorporation of supplementary evidence and criteria that capture additional dimensions of value.To study the practices, processes and policies of value-assessment...